<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thrombolysis was used in 3.7% of <z:hpo ids='HP_0001297'>stroke</z:hpo> patients who were admitted to the Neurological Departments of Vienna </plain></SENT>
<SENT sid="1" pm="."><plain>High doses of <z:chebi fb="5" ids="28304">heparin</z:chebi> were associated with an increased risk of secondary symptomatic <z:mp ids='MP_0001914'>hemorrhage</z:mp> (OR 10.3; 95% CI 2.4-43.2) </plain></SENT>
<SENT sid="2" pm="."><plain>But none of the patients with <z:hpo ids='HP_0002326'>TIA</z:hpo> or minor <z:hpo ids='HP_0001297'>stroke</z:hpo> who received high dosages of <z:chebi fb="5" ids="28304">heparin</z:chebi> suffered from secondary symptomatic <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Spontaneous or therapeutically induced decrease of the diastolic blood pressure by more than 20 mmHg was associated with a three-fold risk of an unfortunate functional outcome </plain></SENT>
<SENT sid="4" pm="."><plain>Complications following <z:hpo ids='HP_0001297'>stroke</z:hpo> are frequent and most likely to occur within the first 5 days </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002090'>Pneumonia</z:hpo> was found to be an independent risk factor for an unfortunate functional outcome after three months </plain></SENT>
<SENT sid="6" pm="."><plain>A main field of activity of <z:hpo ids='HP_0001297'>stroke</z:hpo> units should be to prevent or to early recognize and treat complications </plain></SENT>
</text></document>